Bryant David Lim

PRLD

Bryant David Lim serves as CLO, Interim CFO, Corp Sec. at Prelude Therapeutics Incorporated (PRLD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$35.6K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$35.6K

Companies Traded

PRLD

Active Period

May 2023 – Dec 2024

2 total trades

Most Recent

Buy PRLD

Dec 20, 2024 · $22.6K

Bryant David Lim's Insider Trading at Prelude Therapeutics Incorporated (PRLD)

Buys

2 · $35.6K

Sells

0 · $0.00

Total Shares Bought

27,400

Total Shares Sold

PRLD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 20, 2024	Buy	25,000	$0.91	$22.6K	27,400
May 25, 2023	Buy	2,400	$5.39	$12.9K	2,400

Related Insiders

David P Bonita

director, 10 percent owner:

PRLDBuy · Apr 23, 2026

ORBIMED ADVISORS LLC

director, 10 percent owner:

PRLDBuy · Apr 23, 2026

BAKER BROS. ADVISORS LP

director, 10 percent owner:

PRLDBuy · Apr 22, 2026

Jane Huang

President, CMO

PRLDSell · Oct 4, 2025

Explore More Insider Trading Data

PRLD Insider Trading Activity

View all insider trades at Prelude Therapeutics Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity